ArazMarachelianMD
Pediatric Hematology & Oncology • Los Angeles, CAAssistant Professor, Pediatrics, USC School of Medicine
Dr. Marachelian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 323-361-2121Fax+1 323-361-7128- Is this information wrong?
Education & Training
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2003 - 2006- Children's Hospital Los AngelesResidency, Pediatrics, 2000 - 2003
University of California, Irvine, School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2002 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- N99-02: Melphalan and Buthionine Sulfoximine Start of enrollment: 2001 Aug 01
- N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma Start of enrollment: 2009 Dec 01
- N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma Start of enrollment: 2010 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.Michael D Hogarty, David S Ziegler, Andrea Franson, Yueh-Yun Chi, Denice Tsao-Wei, Kangning Liu, Rohan Vemu, Eugene W Gerner, Elizabeth Bruckheimer, Anasheh Shamirian,...> ;British Journal of Cancer. 2024 Mar 1
- Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi-site longitudinal survey study.Cohn, S. L., Erica C Kaye, Jesse Smith, Yiwang Zhou, Rochelle Bagatell, Justin N Baker, Susan L Cohn, Lisa R Diller, Julia L Glade Bender, M Meaghan Granger, Araz Mara...> ;Cancer. 2024 Apr 1
- Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma.Danny Lascano, Michael J Zobel, William G Lee, Stephanie Y Chen, Abigail Zamora, Grace E Asuelime, So Yung Choi, Antonios Chronopoulos, Shahab Asgharzadeh, Araz Marach...> ;Scientific Reports. 2023 Nov 14
- Join now to see all
Lectures
- A phase I NANT study of lenalidomide with ch14.18 and isotretinoin (RA) in patients with refractory/recurrent neuroblastoma (RR-NB).2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- NANT 2012-01: Phase 1 study of DFMO and celecoxib with cyclophosphamide and topotecan for relapsed or refractory high-risk neuroblastoma.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Press Mentions
- Children's Hospital Los Angeles Part of Clinical Trials for Neuroblastoma Radiation TherapyJuly 15th, 2022
- Children’s Hospital Los Angeles Offers MIBG Therapy for NeuroblastomaJuly 14th, 2022
- Ellis Injury Law Firm Proud to Donate to Create a Smile CharityNovember 4th, 2020
- Join now to see all
Hospital Affiliations
Children's Hospital Los AngelesLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
